» Articles » PMID: 25122922

The Natural Product Phyllanthusmin C Enhances IFN-γ Production by Human NK Cells Through Upregulation of TLR-mediated NF-κB Signaling

Abstract

Natural products are a major source for cancer drug development. NK cells are a critical component of innate immunity with the capacity to destroy cancer cells, cancer-initiating cells, and clear viral infections. However, few reports describe a natural product that stimulates NK cell IFN-γ production and unravel a mechanism of action. In this study, through screening, we found that a natural product, phyllanthusmin C (PL-C), alone enhanced IFN-γ production by human NK cells. PL-C also synergized with IL-12, even at the low cytokine concentration of 0.1 ng/ml, and stimulated IFN-γ production in both human CD56(bright) and CD56(dim) NK cell subsets. Mechanistically, TLR1 and/or TLR6 mediated PL-C's activation of the NF-κB p65 subunit that in turn bound to the proximal promoter of IFNG and subsequently resulted in increased IFN-γ production in NK cells. However, IL-12 and IL-15Rs and their related STAT signaling pathways were not responsible for the enhanced IFN-γ secretion by PL-C. PL-C induced little or no T cell IFN-γ production or NK cell cytotoxicity. Collectively, we identify a natural product with the capacity to selectively enhance human NK cell IFN-γ production. Given the role of IFN-γ in immune surveillance, additional studies to understand the role of this natural product in prevention of cancer or infection in select populations are warranted.

Citing Articles

B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer.

Zhu Z, Teng K, Zhou J, Xu Y, Zhang L, Zhao H Front Oncol. 2022; 12:814312.

PMID: 35311080 PMC: 8929685. DOI: 10.3389/fonc.2022.814312.


Screening for Active Compounds Targeting Human Natural Killer Cell Activation Identifying Daphnetin as an Enhancer for IFN-γ Production and Direct Cytotoxicity.

Yao B, Yang Q, Yang Y, Li Y, Peng H, Wu S Front Immunol. 2021; 12:680611.

PMID: 34956168 PMC: 8693168. DOI: 10.3389/fimmu.2021.680611.


Advances in plant-derived natural products for antitumor immunotherapy.

Yang Y, Liu Q, Shi X, Zheng Q, Chen L, Sun Y Arch Pharm Res. 2021; 44(11):987-1011.

PMID: 34751930 DOI: 10.1007/s12272-021-01355-1.


Development of Broad-Spectrum Antiviral Agents-Inspiration from Immunomodulatory Natural Products.

Zhang M, Zhong J, Xiong Y, Song X, Li C, He Z Viruses. 2021; 13(7).

PMID: 34203182 PMC: 8310077. DOI: 10.3390/v13071257.


Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect.

Zhou X, Yu L, Zhou M, Hou P, Yi L, Mi M Nutr Metab (Lond). 2021; 18(1):64.

PMID: 34147124 PMC: 8214786. DOI: 10.1186/s12986-021-00589-6.


References
1.
Newman D, Cragg G . Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012; 75(3):311-35. PMC: 3721181. DOI: 10.1021/np200906s. View

2.
King A, Jokhi P, Burrows T, Gardner L, Sharkey A, Loke Y . Functions of human decidual NK cells. Am J Reprod Immunol. 1996; 35(3):258-60. DOI: 10.1111/j.1600-0897.1996.tb00041.x. View

3.
Kane A, Yang I . Interferon-gamma in brain tumor immunotherapy. Neurosurg Clin N Am. 2009; 21(1):77-86. DOI: 10.1016/j.nec.2009.08.011. View

4.
Dunn G, Koebel C, Schreiber R . Interferons, immunity and cancer immunoediting. Nat Rev Immunol. 2006; 6(11):836-48. DOI: 10.1038/nri1961. View

5.
Fauriat C, Long E, Ljunggren H, Bryceson Y . Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood. 2009; 115(11):2167-76. PMC: 2844017. DOI: 10.1182/blood-2009-08-238469. View